Nutriband up after FDA grants meeting for firm's fentanyl patch

** Shares of transdermal pharma products maker Nutriband NTRB rise 3.5% to $7.38

** Nutriband says FDA grants meeting request for co's fentanyl patch

** The meeting is scheduled for September 18 in which the regulator will provide feedback on co's marketing application for fentanyl patch

** NTRB is developing Aversa, a proprietary technology that makes transdermal patches safer by preventing abuse and misuse of potent opioids like fentanyl

** Including session moves, stock up 52.44% YTD